SWI as an Alternative to Contrast-Enhanced Imaging to Detect Acute MS Lesions

References

1. 1.↵
   1. Chen W,
   2. Gauthier SA,
   3. Gupta A, et al

   . Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014;271:183–92 doi:10.1148/radiol.13130353 pmid:24475808

   CrossRefPubMed
2. 2.↵
   1. Zhang Y,
   2. Gauthier SA,
   3. Gupta A, et al

   . Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM). J Magn Reson Imaging 2016;44:426–32 doi:10.1002/jmri.25144 pmid:26800367

   CrossRefPubMed
3. 3.↵
   1. Zhang Y,
   2. Gauthier SA,
   3. Gupta A, et al

   . Quantitative susceptibility mapping and R2* measured changes during white matter lesion development in multiple sclerosis: myelin breakdown, myelin debris degradation and removal, and iron accumulation. AJNR Am J Neuroradiol 2016;37:1629–35 doi:10.3174/ajnr.A4825 pmid:27256856

   Abstract/FREE Full Text
4. 4.↵
   1. Vinayagamani S,
   2. Sabarish S,
   3. Nair SS, et al

   . Quantitative susceptibility-weighted imaging in predicting disease activity in multiple sclerosis. Neuroradiology 2021;63:1061–69 doi:10.1007/s00234-020-02605-7 pmid:33403447

   CrossRefPubMed
5. 5.↵
   1. Zhang XS,
   2. Nguyen TD,
   3. Ruá SM, et al

   . Quantitative susceptibility mapping of time-dependent susceptibility changes in multiple sclerosis lesions. AJNR Am J Neuroradiol 2019;40:987–93 doi:10.3174/ajnr.A6071 pmid:31097429

   Abstract/FREE Full Text
6. 6.↵
   1. Chawla S,
   2. Kister I,
   3. Wuerfel J, et al

   . Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7T MRI. AJNR Am J Neuroradiol 2016;37:1223–30 doi:10.3174/ajnr.A4729 pmid:27012298

   Abstract/FREE Full Text
7. 7.↵
   1. Chawla S,
   2. Kister I,
   3. Sinnecker T, et al

   . Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging. PLoS One 2018;13:e0202918 doi:10.1371/journal.pone.0202918 pmid:30212476

   CrossRefPubMed
8. 8.↵
   1. Caruana G,
   2. Pessini LM,
   3. Cannella R, et al

   . Texture analysis in susceptibility-weighted imaging may be useful to differentiate acute from chronic multiple sclerosis lesions. Eur Radiol 2020;30:6348 356 doi:10.1007/s00330-020-06995-3 pmid:32535736

   CrossRefPubMed
9. 9.↵
   1. Deh K,
   2. Ponath GD,
   3. Molvi Z, et al

   . Magnetic susceptibility increases as diamagnetic molecules breakdown: myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM. J Magn Reson Imaging 2018;48:1281–87 doi:10.1002/jmri.25997 pmid:29517817

   CrossRefPubMed
10. 10.↵
    1. Polman CH,
    2. Reingold SC,
    3. Banwell B, et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Bian W,
    2. Harter K,
    3. Hammond-Rosenbluth KE, et al

    . A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler 2013;19:69–75 doi:10.1177/1352458512447870 pmid:22641301

    CrossRefPubMed
12. 12.↵
    1. Mehta V,
    2. Pei W,
    3. Yang G, et al

    . Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One 2013;8:e57573 doi:10.1371/journal.pone.0057573 pmid:23516409

    CrossRefPubMed
13. 13.↵
    1. Bozin I,
    2. Ge Y,
    3. Kuchling J, et al

    . Magnetic resonance phase alterations in multiple sclerosis patients with short and long disease duration. PLoS One 2015;10:e0128386 doi:10.1371/journal.pone.0128386 pmid:26186349

    CrossRefPubMed
14. 14.↵
    1. Eisele P,
    2. Fischer K,
    3. Szabo K, et al

    . Characterization of contrast-enhancing and non-contrast-enhancing multiple sclerosis lesions using susceptibility-weighted imaging. Front Neurol 2019;10:1–7 doi:10.3389/fneur.2019.01082 pmid:31681152

    CrossRefPubMed
15. 15.↵
    1. Blindenbacher N,
    2. Brunner E,
    3. Asseyer S, et al

    . Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis. Mult Scler J Exp Transl Clin 2020;6:2055217320915480 doi:10.1177/2055217320915480 pmid:32284875

    CrossRefPubMed
16. 16.↵
    1. Cotton F,
    2. Weiner HL,
    3. Jolesz FA, et al

    . MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 2003;60:640–46 doi:10.1212/01.wnl.0000046587.83503.1e pmid:12601106

    Abstract/FREE Full Text
17. 17.↵
    1. Hametner S,
    2. Wimmer I,
    3. Haider L, et al

    . Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 2013;74:848–61 doi:10.1002/ana.23974 pmid:23868451

    CrossRefPubMed
18. 18.↵
    1. Frischer JM,
    2. Weigand SD,
    3. Guo Y, et al

    . Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 2015;78:710–21 doi:10.1002/ana.24497 pmid:26239536

    CrossRefPubMed
19. 19.↵
    1. Dal-Bianco A,
    2. Grabner G,
    3. Kronnerwetter C, et al

    . Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 2017;133:25–42 doi:10.1007/s00401-016-1636-z pmid:27796537

    CrossRefPubMed
20. 20.↵
    1. Bagnato F,
    2. Hametner S,
    3. Yao B, et al

    . Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134:3602–15 doi:10.1093/brain/awr278 pmid:22171355

    CrossRefPubMed
21. 21.↵
    1. Absinta M,
    2. Sati P,
    3. Gaitán MI, et al

    . Seven-Tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann Neurol 2013;74:669–78 doi:10.1002/ana.23959 pmid:23813441

    CrossRefPubMed
22. 22.↵
    1. Kaunzner UW,
    2. Kang Y,
    3. Zhang S, et al

    . Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain 2019;142:133–45 doi:10.1093/brain/awy296 pmid:30561514

    CrossRefPubMed
23. 23.↵
    1. Suzuki M,
    2. Kudo K,
    3. Sasaki M, et al

    . Detection of active plaques in multiple sclerosis using susceptibility-weighted imaging: comparison with gadolinium-enhanced MR imaging. Magn Reson Med Sci 2011;10:185–92 doi:10.2463/mrms.10.185 pmid:21960001

    CrossRefPubMed
24. 24.↵
    1. Jang J,
    2. Nam Y,
    3. Choi Y, et al

    . Paramagnetic rims in multiple sclerosis and neuromyelitis optica spectrum disorder: a quantitative susceptibility mapping study with 3-T MRI. J Clin Neurol 2020;16:562–72 doi:10.3988/jcn.2020.16.4.562 pmid:33029961

    CrossRefPubMed